IMMUNOSENS logo — Creating precise measurements for diagnoses and food safety...

IMMUNOSENS

Creating precise measurements for diagnoses and food safety inspections through advanced electrochemical sensor technology.

Founded 2018 Series B Total: $315.00M Biotechnology, Medical Devices

General Information

Company Name IMMUNOSENS
Founded Year 2018
Industries Biotechnology, Medical Devices
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with IMMUNOSENS. To contact IMMUNOSENS, visit immunosens.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does IMMUNOSENS compare?

A PDF of IMMUNOSENS and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting IMMUNOSENS soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About IMMUNOSENS

IMMUNOSENS is a biotechnology startup founded in 2018, dedicated to creating precise measurements for diagnoses and food safety inspections through advanced electrochemical sensor technology. The company's product incorporates disposable printable electrodes in its sensors, offering healthcare professionals precise analysis and measurements for diagnostic purposes and food safety inspections. Immunological, which operates in the Biotechnology and Medical Devices industries, recently secured a Series B investment on 02 February 2023, with Global Brain as the lead investor. This investment signifies a significant milestone for the company as it continues to advance its innovative technology and expand its market presence.

Business keywords: electrochemical sensors, biomarker analysis, diagnostic devices, food safety inspections, electrode reactions, biomarker evaluation, printable electrodes, healthcare diagnostics

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series B Undisclosed 1
Global Brain
02 Feb 2023
Series B ¥130.00M 2
Osaka University Venture Capital, Mehagen
30 Mar 2021
Series A ¥125.00M 1
Osaka University Venture Capital
02 Dec 2019
Seed Round ¥60.00M 1
Osaka University Venture Capital
24 Apr 2018

IMMUNOSENS Alternatives & Competitors

View All Alternatives
IMMUNOSENS vs
MNCHIP
MNCHIP China

Tianjin MNCHIP Technologies Co., Ltd is a provider of microfluidic devices in in-vitro diagnostics (...

Series B
16 employees
Biotechnology, Health Care
IMMUNOSENS vs
Mellitus, LLC
Mellitus, LLC United States

Mellitus developed a simple diagnostic test for gestational diabetes-Work continues at Harvard/MassG...

5 employees
Biotechnology, Health Care
IMMUNOSENS vs
NovaSom, Inc.
NovaSom, Inc. United States

NovaSom is a privately held diagnostic-service provider for home testing and evaluation of obstructi...

Debt Financing
54 employees
Biotechnology, Medical Devices

FAQ About IMMUNOSENS

Creating precise measurements for diagnoses and food safety inspections through advanced electrochemical sensor technology.
IMMUNOSENS was founded in 2018.
IMMUNOSENS operates in Biotechnology and Medical Devices. Its work centres on electrochemical sensors, biomarker analysis, diagnostic devices and food safety inspections.
IMMUNOSENS has completed 4 funding rounds, raising a total of $315.00M. The latest funding stage is Series B.
Top alternatives and competitors to IMMUNOSENS include MNCHIP, Mellitus, LLC, NovaSom, Inc., INTA Systems, Autonomous Medical Devices Incorporated. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
IMMUNOSENS and MNCHIP are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for IMMUNOSENS, https://bouncewatch.com/company/immunosens, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes